The proportion of patients with increased intrathecal immunoglobulin synthesis (IgG, IgM, or IgA) and positive OCBs, both used as diagnostic parameters for MS, was significantly higher in MS-patients (p < 0.001 for both comparisons). The gene discussed is CD79A; the disease is myeloid sarcoma.